141 related articles for article (PubMed ID: 12037089)
1. Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis.
Mäkinen J; Mertsola J; Viljanen MK; Arvilommi H; He Q
J Clin Microbiol; 2002 Jun; 40(6):2213-6. PubMed ID: 12037089
[TBL] [Abstract][Full Text] [Related]
2. Comparison of real-time PCR and pyrosequencing for typing Bordetella pertussis toxin subunit 1 variants.
Storm M; Advani A; Pettersson M; Hallander HO; Bondeson K
J Microbiol Methods; 2006 Apr; 65(1):153-8. PubMed ID: 16095736
[TBL] [Abstract][Full Text] [Related]
3. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.
Mäkinen J; Viljanen MK; Mertsola J; Arvilommi H; He Q
Emerg Infect Dis; 2001; 7(6):952-8. PubMed ID: 11747721
[TBL] [Abstract][Full Text] [Related]
4. Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.
Muyldermans G; Piérard D; Hoebrekx N; Advani R; Van Amersfoorth S; De Schutter I; Soetens O; Eeckhout L; Malfroot A; Lauwers S
J Clin Microbiol; 2004 Apr; 42(4):1614-9. PubMed ID: 15071014
[TBL] [Abstract][Full Text] [Related]
5. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.
Mooi FR; He Q; van Oirschot H; Mertsola J
Infect Immun; 1999 Jun; 67(6):3133-4. PubMed ID: 10338531
[TBL] [Abstract][Full Text] [Related]
6. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
Byrne S; Slack AT
BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
[TBL] [Abstract][Full Text] [Related]
8. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA
Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221
[TBL] [Abstract][Full Text] [Related]
9. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
[TBL] [Abstract][Full Text] [Related]
10. Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.
Peppler MS; Kuny S; Nevesinjac A; Rogers C; de Moissac YR; Knowles K; Lorange M; De Serres G; Talbot J
J Clin Microbiol; 2003 Jul; 41(7):3344-7. PubMed ID: 12843089
[TBL] [Abstract][Full Text] [Related]
11. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
Packard ER; Parton R; Coote JG; Fry NK
J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
[TBL] [Abstract][Full Text] [Related]
12. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
Mooi FR; van Oirschot H; Heuvelman K; van der Heide HG; Gaastra W; Willems RJ
Infect Immun; 1998 Feb; 66(2):670-5. PubMed ID: 9453625
[TBL] [Abstract][Full Text] [Related]
14. Bordetella pertussis PCR: simultaneous targeting of signature sequences.
Qin X; Turgeon DK; Ingersoll BP; Monsaas PW; Lemoine CJ; Tsosie T; Stapp LO; Abe PM
Diagn Microbiol Infect Dis; 2002 Aug; 43(4):269-75. PubMed ID: 12151186
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.
Mooi FR; Hallander H; Wirsing von König CH; Hoet B; Guiso N
Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):174-81. PubMed ID: 10795589
[TBL] [Abstract][Full Text] [Related]
16. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
Hausman SZ; Burns DL
Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection.
Nygren M; Reizenstein E; Ronaghi M; Lundeberg J
J Clin Microbiol; 2000 Jan; 38(1):55-60. PubMed ID: 10618063
[TBL] [Abstract][Full Text] [Related]
19. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
20. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines.
van Loo IHM; Mooi FR
Microbiology (Reading); 2002 Jul; 148(Pt 7):2011-2018. PubMed ID: 12101289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
